Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2022

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

Caitlin E. Cox

September 16, 2022

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

Presentation TCT 2014

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow

September 13, 2014

Presentation TCT 2013

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Presenter: Mathew Williams

October 31, 2013

Presentation TCT 2013

Guidelines for Commercial TAVR Site Selection in the United States

Presenter: Rhonda Robb

October 31, 2013

Presentation TCT 2013

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on "When to Treat"

Presenter: Karl-Heinz Kuck

October 28, 2013

Presentation TCT 2013

My Crystal Ball: How Will the Aortic Stenosis Guidelines Change in the Next Decade with the Integration of TAVR?

Presenter: Robert Bonow

October 27, 2013

Advertisement

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

TCT 2019 Day Two: Transcatheter Valves, New and Old

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Global TAVR Market Poised to Exceed DES Market by 2025

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Guidelines for Commercial TAVR Site Selection in the United States

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on "When to Treat"

My Crystal Ball: How Will the Aortic Stenosis Guidelines Change in the Next Decade with the Integration of TAVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content